Edward Guilmette

Edward Guilmette is a Scientist II at Biogen, a biotechnology company, based in Cambridge, Massachusetts.1 He has been in this role since December 2020, focusing on gene therapy research and development.1

Professional Experience

Guilmette's career at Biogen began in April 2018 when he joined as a Scientist I.1 His current responsibilities include:

• Leading a preclinical Gene Therapy program for ALS (Amyotrophic Lateral Sclerosis)
• Serving as a cargo engineer for other potential CNS (Central Nervous System) Gene Therapy programs1

Prior to joining Biogen, Guilmette had an extensive career in the pharmaceutical industry:

• Senior Scientist at Pfizer (June 2009 - April 2018)
• Scientist at Pfizer (June 2001 - June 2009)
• Senior Associate Scientist at Pfizer (March 1997 - June 2001)
• Assistant Scientist at Bayer (1993 - 1997)
• Associate Scientist at Alexion (1991 - 1994)1

Education

Guilmette has a strong educational background in neurobiology and biotechnology:

• M.S. in Biotechnology from the University of Connecticut (1992 - 1996)
• B.S. in Neurobiology from the University of Connecticut (1987 - 1991)1

His educational background and extensive experience in the pharmaceutical and biotechnology industries have equipped him with the skills necessary for his current role in gene therapy research at Biogen.